Search / Trial NCT00002117

A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

Launched by HOFFMANN-LA ROCHE · Aug 30, 2001

Trial Information

Current as of December 26, 2024

Completed

Keywords

Zalcitabine Drug Therapy, Combination Acquired Immunodeficiency Syndrome Aids Related Complex Zidovudine

ClinConnect Summary

Patients are randomized to one of four treatment arms. ddC is administered at 1 of 2 doses every 8 hours. AZT is administered at 1 of 2 doses (every 4 hours while awake or every 8 hours).

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • Patients must have:
  • HIV infection.
  • CD4 count 100 - 500 cells/mm3.

About Hoffmann La Roche

Hoffmann-La Roche, commonly known as Roche, is a global leader in biotechnology and pharmaceuticals, committed to advancing healthcare through innovative research and development. With a strong focus on oncology, immunology, infectious diseases, and central nervous system disorders, Roche leverages cutting-edge science to deliver transformative therapies and diagnostics. The company is dedicated to improving patient outcomes by conducting rigorous clinical trials and collaborating with healthcare professionals and organizations worldwide. Roche's unwavering commitment to precision medicine and personalized healthcare positions it at the forefront of the industry, driving progress in the quest for effective treatments and improved patient care.

Locations

Columbus, Ohio, United States

Chicago, Illinois, United States

Miami, Florida, United States

Miami, Florida, United States

Harbor City, California, United States

San Francisco, California, United States

Washington, District Of Columbia, United States

Wichita, Kansas, United States

Milwaukee, Wisconsin, United States

Galveston, Texas, United States

Dallas, Texas, United States

Los Angeles, California, United States

Boston, Massachusetts, United States

Brooklyn, New York, United States

Denver, Colorado, United States

Albuquerque, New Mexico, United States

New York, New York, United States

Portland, Oregon, United States

Bronx, New York, United States

San Diego, California, United States

Washington, District Of Columbia, United States

Atlanta, Georgia, United States

St. Paul, Minnesota, United States

St. Louis, Missouri, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials